Back to dashboard
CommercialCoverageMedium impact

08.02.39, Zanidatamab-hrii (Ziihera®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Apr 21, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A new pharmacy policy has been established for Zanidatamab-hrii (Ziihera®), a specialty medication. This represents a new coverage policy that will define billing, prior authorization, and coverage parameters for this drug when the policy becomes effective.

Action Required

Action needed
Before April 21, 2025: Billing team should review the full policy document at the provided URL to understand coverage criteria, prior authorization requirements, and billing procedures for Zanidatamab-hrii (Ziihera®). Update pharmacy billing protocols and staff training accordingly once complete policy details are available.

Related policy hubs